Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector

The COVID-19 pandemic emerged in 2020 and has caused an unprecedented burden to all countries in the world. SARS-CoV-2 continues to circulate and antigenically evolve, enabling multiple reinfections. To address the issue of the virus antigenic variability, T cell-based vaccines are being developed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Isakova-Sivak, Irina, Stepanova, Ekaterina, Matyushenko, Victoria, Niskanen, Sergei, Mezhenskaya, Daria, Bazhenova, Ekaterina, Krutikova, Elena, Kotomina, Tatiana, Prokopenko, Polina, Neterebskii, Bogdan, Doronin, Aleksandr, Vinogradova, Elena, Yakovlev, Kirill, Sivak, Konstantin, Rudenko, Larisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318028/
https://www.ncbi.nlm.nih.gov/pubmed/35891306
http://dx.doi.org/10.3390/vaccines10071142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318028/
https://www.ncbi.nlm.nih.gov/pubmed/35891306
http://dx.doi.org/10.3390/vaccines10071142

Ejemplares similares